US FDA’s Review of Single-Country ‘Me Too’ Drugs: A Clinical Trialist Perspective

… of care and limited resources to review applications, researchers say they support the agency’s decision not to …

World Conference Conversations: Inside WCLC 2025

… to reflect on the latest advances and cutting-edge research in thoracic oncology. Noemi Reguart, MD, PhD In early …

Oral Abstract Presentations to Focus on the Application of Multidisciplinary Care

… On Monday, August 8, four researchers will share data showing the benefits of …

Mesothelioma Patients Experienced Higher Levels of Toxicity on CheckMate743 Regimen Than Reported in Clinical Trials

… of unresectable pleural mesothelioma. 1  However, research published last month in the  Journal of Thoracic … Vincent’s Hospital, Darlinghurst, Australia, and fellow researchers retrospectively collected demographic and … doi:10.1016/S1470-2045(18)30765-4   … PATIENT RESEARCH ADVOCATE ANGUS PRATT REFLECTS ON THE PAST YEAR OF …

Treatment of Immunotherapy-Related Dermatologic Toxicities: An Interview with Dr. Mario Lacouture

ADRIATIC Demonstrates Meaningful Improvements in OS, PFS in Patients with Limited-stage SCLC

… Spigel, MD, Chief Scientific Officer at the Sarah Cannon Research Institute in Nashville, Tennessee, as he began his …

IASLC Lectureships Focus on Contributions of Leaders in Thoracic Oncology

In Brief for October 12, 2022

… as site for US National Cancer Institute Telehealth Research Center of Excellence. … In Brief for October 12, 2022 …

Arrhythmias after Radiotherapy—What Do (and Don’t) We Know?

Modified Lung Cancer Screening Eligibility Requirements May Reduce Racial Disparities in Lung Cancer Screening, Treatment

… According to research presented during the North America Conference on Lung …

Patient Advocate Ivy B. Elkins Leaves Lasting Legacy